Greenhouse Funds LLLP Grows Stake in Astera Labs, Inc. $ALAB

Key Points

• Greenhouse Funds LLLP increased its stake in Astera Labs, Inc. by 34.7% in the first quarter, now holding approximately 0.21% of the company, valued at about $20.4 million.
• Other institutional investors, including UBS AM, significantly boosted their stakes, with UBS increasing its position by 2,824.4% last quarter.
• Astera Labs reported quarterly earnings of $0.44 per share, surpassing estimates, with revenues rising 149.5% year-over-year.

Greenhouse Funds LLLP increased its stake in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 34.7% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 341,530 shares of the company's stock after acquiring an additional 88,038 shares during the period. Greenhouse Funds LLLP owned approximately 0.21% of Astera Labs worth $20,379,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in Astera Labs by 2,824.4% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 154,524 shares of the company's stock worth $20,467,000 after acquiring an additional 149,240 shares in the last quarter. Aigen Investment Management LP boosted its position in shares of Astera Labs by 50.9% during the first quarter. Aigen Investment Management LP now owns 17,920 shares of the company's stock valued at $1,069,000 after buying an additional 6,045 shares during the period. Pacific Point Advisors LLC boosted its position in shares of Astera Labs by 75.0% during the first quarter. Pacific Point Advisors LLC now owns 7,000 shares of the company's stock valued at $418,000 after buying an additional 3,000 shares during the period. Oppenheimer Asset Management Inc. boosted its position in shares of Astera Labs by 73.6% during the first quarter. Oppenheimer Asset Management Inc. now owns 15,995 shares of the company's stock valued at $954,000 after buying an additional 6,783 shares during the period. Finally, Taylor Frigon Capital Management LLC purchased a new position in shares of Astera Labs during the first quarter valued at approximately $1,887,000. Hedge funds and other institutional investors own 60.47% of the company's stock.

Insider Buying and Selling

In other Astera Labs news, CFO Michael Truett Tate sold 18,861 shares of the company's stock in a transaction on Monday, August 18th. The shares were sold at an average price of $183.51, for a total value of $3,461,182.11. Following the sale, the chief financial officer directly owned 259,512 shares of the company's stock, valued at approximately $47,623,047.12. This represents a 6.78% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, General Counsel Philip Mazzara sold 10,000 shares of the company's stock in a transaction on Thursday, August 28th. The shares were sold at an average price of $188.70, for a total transaction of $1,887,000.00. Following the completion of the sale, the general counsel directly owned 161,573 shares in the company, valued at approximately $30,488,825.10. The trade was a 5.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 1,649,489 shares of company stock valued at $232,463,986 in the last 90 days. 12.50% of the stock is currently owned by insiders.

Astera Labs Price Performance

NASDAQ ALAB opened at $176.61 on Thursday. The stock's fifty day moving average price is $137.83 and its 200 day moving average price is $97.51. Astera Labs, Inc. has a 1 year low of $36.85 and a 1 year high of $199.47. The company has a market cap of $29.36 billion, a price-to-earnings ratio of 315.38, a PEG ratio of 4.62 and a beta of 1.48.

Astera Labs (NASDAQ:ALAB - Get Free Report) last released its earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.33 by $0.11. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.The firm had revenue of $191.93 million for the quarter, compared to the consensus estimate of $172.46 million. During the same period in the prior year, the firm earned $0.13 EPS. The firm's revenue was up 149.5% on a year-over-year basis. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Research analysts expect that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Analyst Ratings Changes

Several brokerages have issued reports on ALAB. Jefferies Financial Group boosted their target price on Astera Labs from $95.00 to $130.00 and gave the company a "buy" rating in a research report on Tuesday, July 22nd. Zacks Research upgraded Astera Labs to a "strong-buy" rating in a research report on Tuesday, August 12th. CICC Research initiated coverage on Astera Labs in a research report on Friday, August 29th. They set an "outperform" rating and a $190.00 target price for the company. Barclays reaffirmed an "overweight" rating and set a $155.00 price target (up previously from $75.00) on shares of Astera Labs in a research note on Thursday, August 7th. Finally, Susquehanna lifted their price target on shares of Astera Labs from $80.00 to $125.00 and gave the company a "neutral" rating in a research note on Thursday, August 7th. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and three have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $142.00.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.